Literature DB >> 34520955

Synthesis and biological evaluation of indole-based peptidomimetics as antibacterial agents against Gram-positive bacteria.

Yongzhi Chen1, Hongxia Li1, Jiayong Liu1, Rongcui Zhong1, Haizhou Li1, Shanfang Fang1, Shouping Liu2, Shuimu Lin3.   

Abstract

The emergence of bacterial multidrug resistance and the lack of new antimicrobial agents urgently demand the discovery and development of novel antibacterials that avoid bacterial resistance. Antimicrobial peptidomimetics represent a promising approach for overcoming antibiotic resistance. Herein we report the synthesis and evaluation of indole-based amphiphilic antimicrobial peptidomimetics, bearing hydrophobic side chains and hydrophilic cationic moieties. Among these derivatives, compound 28 demonstrated potent antimicrobial activity against Gram-positive bacteria, low hemolytic activity and low toxicity towards mammalian cells, as well as good stability in salt conditions. Moreover, compound 28 showed the rapid killing of bacteria via membrane-targeting action without developing bacterial resistance. More importantly, compound 28 displayed high antimicrobial potency against Gram-positive bacteria in a murine model of bacterial keratitis, and was found to be more efficient than vancomycin. Thus, compound 28 had great potential as a promising lead compound for the treatment of Gram-positive bacterial infection.
Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Antimicrobial agents; Bacterial resistance; Indole; Membrane-targeting; Peptidomimetics

Mesh:

Substances:

Year:  2021        PMID: 34520955     DOI: 10.1016/j.ejmech.2021.113813

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  3 in total

1.  Repurposing the Sphingosine-1-Phosphate Receptor Modulator Etrasimod as an Antibacterial Agent Against Gram-Positive Bacteria.

Authors:  Matej Zore; Shella Gilbert-Girard; Paola San-Martin-Galindo; Inés Reigada; Leena Hanski; Kirsi Savijoki; Adyary Fallarero; Jari Yli-Kauhaluoma; Jayendra Z Patel
Journal:  Front Microbiol       Date:  2022-06-06       Impact factor: 6.064

Review 2.  Antimicrobial Peptide Mimics for Clinical Use: Does Size Matter?

Authors:  Johan Svenson; Natalia Molchanova; Christina I Schroeder
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

3.  Human defensin-inspired discovery of peptidomimetic antibiotics.

Authors:  Gan Luo; Jue Zhang; HanBin Wang; YaQi Sun; BaoLi Cheng; ZhiPeng Xu; Yan Zhang; Hui Li; WuYuan Lu; Elizabeta Nemeth; Tomas Ganz; XiangMing Fang
Journal:  Proc Natl Acad Sci U S A       Date:  2022-03-01       Impact factor: 12.779

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.